These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 6107859)

  • 1. Somatostatin selectively inhibits noradrenaline release from hypothalamic neurones.
    Göthert M
    Nature; 1980 Nov; 288(5786):86-8. PubMed ID: 6107859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatostatin facilitates the serotonin release from rat cerebral cortex, hippocampus and hypothalamus slices.
    Tanaka S; Tsujimoto A
    Brain Res; 1981 Mar; 208(1):219-22. PubMed ID: 6110467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatostatin28(15-28), but not somatostatin28(1-12), affects central monoaminergic neurotransmission in rats.
    Vécsei L; Widerlöv E; Alling C; Zsigó J; Pávó I; Penke B
    Neuropeptides; 1990 Aug; 16(4):181-6. PubMed ID: 1703283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Release of somatostatin from extra-hypothalamic rat brain slices: inhibition by dopamine and morphine.
    Lee CM; Iversen LL
    Brain Res; 1981 Aug; 219(2):355-61. PubMed ID: 6114785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of bretylium and guanethidine on 3H-noradrenaline and 3H-serotonin release in rat brain cortex slices.
    Schlicker E; Göthert M
    Arch Int Pharmacodyn Ther; 1983 Feb; 261(2):196-204. PubMed ID: 6220681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of H-Phe-Ile-Tyr-His-Ser-Tyr-Lys-OH on the in vitro uptake and release of radiolabelled dopamine, noradrenaline and serotonin in rat brain hypothalamic slices.
    Telegdy G; Vécsei L; Coy DH; Schally AV
    Neuropeptides; 1984 May; 4(3):251-6. PubMed ID: 6462380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of ethanol on the efflux and release of norepinephrine and 5-hydroxytryptamine from slices of rat hypothalamus.
    Hyatt MC; Tyce GM
    Brain Res; 1985 Jul; 337(2):255-62. PubMed ID: 2992679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noradrenaline stimulates somatostatin release from incubated slices of the amygdala and the hypothalamic preoptic area.
    Epelbaum J; Tapia-Arancibia L; Kordon C
    Brain Res; 1981 Jun; 215(1-2):393-7. PubMed ID: 6114780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of dopamine on neurohypophysial hormone release in vivo and from the rat neural lobe and hypothalamus in vitro.
    Bridges TE; Hillhouse EW; Jones MT
    J Physiol; 1976 Sep; 260(3):647-66. PubMed ID: 988183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obestatin inhibits dopamine release in rat hypothalamus.
    Brunetti L; Di Nisio C; Recinella L; Orlando G; Ferrante C; Chiavaroli A; Leone S; Di Michele P; Shohreh R; Vacca M
    Eur J Pharmacol; 2010 Sep; 641(2-3):142-7. PubMed ID: 20553917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Release of monoamines from the striatum and hypothalamus: effect of -hydroxybutyrate.
    Bustos G; Roth RH
    Br J Pharmacol; 1972 Sep; 46(1):101-15. PubMed ID: 5084815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth hormone and somatostatin treatment change 5-HT1 receptor activity.
    Popova J; Ivanova E; Tosheva T; Iavorska N
    Gen Pharmacol; 1991; 22(6):1143-6. PubMed ID: 1687396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. External pH changes affect NMDA-evoked and spontaneous release of cholecystokinin, somatostatin and noradrenaline from rat cerebrocortical nerve endings.
    Gemignani A; Paudice P; Longordo F; Raiteri M
    Neurochem Int; 2004 Oct; 45(5):677-85. PubMed ID: 15234110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of immunoreactive somatostatin released from rat nervous system in vitro.
    Sheppard MC; Hendricks S; Hudson A; Kronheim SR
    Biochem J; 1982 Feb; 201(2):321-8. PubMed ID: 6123316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of captopril on [3H]-norepinephrine release in rat central nervous system.
    Tsuda K; Tsuda S; Nishio I; Masuyama Y; Goldstein M
    Clin Exp Pharmacol Physiol; 1995 Sep; 22(9):610-3. PubMed ID: 8542671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxytocin does not act locally in the hypothalamus to elicit norepinephrine release.
    Etgen AM
    Brain Res; 1995 Dec; 703(1-2):242-4. PubMed ID: 8719641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of ghrelin and amylin on dopamine, norepinephrine and serotonin release in the hypothalamus.
    Brunetti L; Recinella L; Orlando G; Michelotto B; Di Nisio C; Vacca M
    Eur J Pharmacol; 2002 Nov; 454(2-3):189-92. PubMed ID: 12421646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine enhancement and depression of glutamate-regulated calcium and electrical activity in hypothalamic neurons.
    van den Pol AN; Cao V; Belousov AB
    J Neurophysiol; 1996 Dec; 76(6):3934-48. PubMed ID: 8985891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of an intracellular calcium chelator on the regulation of electrically evoked [3H]-noradrenaline release from rat hippocampal slices.
    Fredholm BB; Hu PS
    Br J Pharmacol; 1993 Jan; 108(1):126-31. PubMed ID: 8094021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-related effects of cysteamine treatment on hypothalamic and striatal dopamine, noradrenaline and serotonin neurotransmission.
    Vécsei L; Kovács GL; Faludi M; Bollók I; Telegdy G
    Acta Physiol Hung; 1985; 66(2):213-7. PubMed ID: 2864776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.